Literature DB >> 28486135

Recent advances in human flavivirus vaccines.

Iris Scherwitzl1, Juthathip Mongkolsapaja2, Gavin Screaton3.   

Abstract

Dengue (DENV), West Nile (WNV) and Zika (ZIKV) viruses are mosquito-transmitted flaviviruses that cause thousands of human deaths and millions of illnesses each year. In the last decades, epidemic outbreaks of all three flaviviruses emerged and caused a major health and economical problem in many parts of the world. The increasing and expanding burden of flaviviruses has highlighted the need for effective human vaccines against all three viruses. This review provides an overview of the recent progress in DENV, WNV and ZIKV vaccines development with specific focus on candidates in human clinical development.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28486135     DOI: 10.1016/j.coviro.2017.04.002

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  17 in total

Review 1.  Kyasanur Forest Disease in India: innovative options for intervention.

Authors:  Paramasivan Rajaiah
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

2.  Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.

Authors:  Kun Xu; Yufeng Song; Lianpan Dai; Yongli Zhang; Xuancheng Lu; Yijia Xie; Hangjie Zhang; Tao Cheng; Qihui Wang; Qingrui Huang; Yuhai Bi; William J Liu; Wenjun Liu; Xiangdong Li; Chuan Qin; Yi Shi; Jinghua Yan; Dongming Zhou; George F Gao
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

3.  What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?

Authors:  Sarah M Bartsch; Lindsey Asti; Sarah N Cox; David P Durham; Samuel Randall; Peter J Hotez; Alison P Galvani; Bruce Y Lee
Journal:  J Infect Dis       Date:  2019-08-09       Impact factor: 5.226

4.  A systematic approach to the development of a safe live attenuated Zika vaccine.

Authors:  Swee Sen Kwek; Satoru Watanabe; Kuan Rong Chan; Eugenia Z Ong; Hwee Cheng Tan; Wy Ching Ng; Mien T X Nguyen; Esther S Gan; Summer L Zhang; Kitti W K Chan; Jun Hao Tan; October M Sessions; Menchie Manuel; Julien Pompon; Camillus Chua; Sharifah Hazirah; Karl Tryggvason; Subhash G Vasudevan; Eng Eong Ooi
Journal:  Nat Commun       Date:  2018-03-12       Impact factor: 14.919

Review 5.  The immunology of Zika Virus.

Authors:  Abigail Culshaw; Juthathip Mongkolsapaya; Gavin Screaton
Journal:  F1000Res       Date:  2018-02-19

6.  Key Amino Acid Substitution for Infection-Enhancing Activity-Free Designer Dengue Vaccines.

Authors:  Atsushi Yamanaka; Eiji Konishi
Journal:  iScience       Date:  2019-02-18

Review 7.  West Nile virus vaccines - current situation and future directions.

Authors:  Sebastian Ulbert
Journal:  Hum Vaccin Immunother       Date:  2019-07-10       Impact factor: 3.452

8.  Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir.

Authors:  Alex C Stabell; Nicholas R Meyerson; Rebekah C Gullberg; Alison R Gilchrist; Kristofor J Webb; William M Old; Rushika Perera; Sara L Sawyer
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

9.  The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor.

Authors:  Obdulio García-Nicolás; Philip V'kovski; Volker Thiel; Stephanie Pfaender; Nathalie J Vielle; Nadine Ebert; Roland Züst; Jasmine Portmann; Hanspeter Stalder; Véronique Gaschen; Gabrielle Vieyres; Michael Stoffel; Matthias Schweizer; Artur Summerfield; Olivier Engler; Thomas Pietschmann; Daniel Todt; Marco P Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 10.  The key amino acids of E protein involved in early flavivirus infection: viral entry.

Authors:  Tao Hu; Zhen Wu; Shaoxiong Wu; Shun Chen; Anchun Cheng
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.